Covered recipient · General Payments record
CASEY D LANDRENEAU
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$2,440.35
- Reported across 92 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,201.40 | 53 |
| Education | $95.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $148.57 | 7 |
| SOBI, INC | $124.73 | 2 |
| Astellas Pharma US Inc | $99.98 | 5 |
| PFIZER INC. | $98.27 | 4 |
| ABBVIE INC. | $97.45 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $83.16 | 3 |
| Pharmacosmos Therapeutics Inc. | $70.85 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $63.00 | 3 |
| Acerta Pharma LLC | $57.60 | 2 |
| TerSera Therapeutics LLC | $54.75 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $42.59 | 2 |
| Janssen Biotech, Inc. | $38.82 | 2 |
| GlaxoSmithKline, LLC. | $36.66 | 2 |
| Incyte Corporation | $32.01 | 2 |
| Fennec Pharmaceuticals, Inc. | $30.04 | 1 |
| Genmab U.S., Inc. | $25.47 | 1 |
| Lilly USA, LLC | $24.53 | 1 |
| Immunocore Limited | $23.76 | 1 |
| MorphoSys, US Inc. | $22.60 | 1 |
| E.R. Squibb & Sons, L.L.C. | $22.48 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $20.74 | 1 |
| Ipsen Biopharmaceuticals, Inc | $17.71 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $17.53 | 1 |
| TAIHO ONCOLOGY, INC. | $15.41 | 1 |
| GENZYME CORPORATION | $14.38 | 1 |
| Rigel Pharmaceuticals, Inc. | $13.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.